About RECOMBINATION THERAPEUTICS LLC
Recombination Therapeutics (RTx) is a precision oncology company focused on eliminating cancer by targeting DNA Damage Response (DDR) factors, particularly DNA polymerase Theta (Polq), to overcome cancer drug resistance. RTx also provides custom chemical synthesis and drug development services as a contract research organization.
Custom chemical synthesisPharmacokinetic and pharmacology services for drug developmentSmall-molecule synthesisResearch on DNA repair mechanisms and drug targets
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to RECOMBINATION THERAPEUTICS LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.